Bli medlem
Bli medlem

Du är här

2015-04-21

Ablynx: ABLYNX ANNOUNCES WARRANT EXERCISE

REGULATED INFORMATION

GHENT, Belgium, 21 April 2015 - Ablynx[Euronext Brussels: ABLX; OTC: ABYLY]

today announced, in conformity with Title II of the Law of 2 May 2007 and the
Royal Decree of 14 February 2008, that an additional 20,165 common shares
have been issued by the Company in exchange for €112,425.70 as the result of
the exercise of warrants by some employees and consultants of the Company.

As a result of this transaction, Ablynx now has 54,324,572 shares outstanding.

About Ablynx

Ablynxis a biopharmaceutical company engaged in the development ofNanobodies®,
proprietary therapeutic proteins based on single-domain antibody fragments,
which combine the advantages of conventional antibody drugs with some of the
features of small-molecule drugs. Ablynx is dedicated to creating new
medicines which will make a real difference to society. Today, the Company
has more than30 proprietary and partnered programmesin development in various
therapeutic areas including inflammation, haematology, oncology and
respiratory disease. The Company has collaborations with multiple
pharmaceutical companies including AbbVie, Boehringer Ingelheim, Merck&Co.,
Inc, Merck Serono and Novartis. The Company is headquartered in Ghent,
Belgium. More information can be found onwww.ablynx.com.

For more information, please contact Ablynx:

Dr Edwin Moses
CEO
t: +32 (0)9 262 00 07
m: +32 (0)473 39 50 68
e: edwin.moses@ablynx.com

Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e: marieke.vermeersch@ablynx.com

Ablynx media relations Consilium Strategic Communications:

Mary-Jane Elliott, Jonathan Birt, Chris Welsh, Lindsey Neville
t: +44 203 709 5700
e :ablynx@consilium-comms.com

Pdf version of the press release
http://hugin.info/137912/R/1912380/682562.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ablynx via Globenewswire

HUG#1912380

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.